Drug Detail:Januvia (Sitagliptin [ si-ta-glip-tin ])
Generic Name: SITAGLIPTIN PHOSPHATE 25mg
Dosage Form: tablet, film coated
Drug Class: Dipeptidyl peptidase 4 inhibitors
Drug Detail:Januvia (Sitagliptin [ si-ta-glip-tin ])
Generic Name: SITAGLIPTIN PHOSPHATE 25mg
Dosage Form: tablet, film coated
Drug Class: Dipeptidyl peptidase 4 inhibitors
The recommended dose of JANUVIA is 100 mg once daily. JANUVIA can be taken with or without food.
Assess renal function prior to initiation of JANUVIA and periodically thereafter.
For patients with an estimated glomerular filtration rate [eGFR] greater than or equal to 45 mL/min/1.73 m2 to less than 90 mL/min/1.73 m2, no dosage adjustment for JANUVIA is required.
For patients with moderate renal impairment (eGFR greater than or equal to 30 mL/min/1.73 m2 to less than 45 mL/min/1.73 m2), the dose of JANUVIA is 50 mg once daily.
For patients with severe renal impairment (eGFR less than 30 mL/min/1.73 m2) or with end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis, the dose of JANUVIA is 25 mg once daily. JANUVIA may be administered without regard to the timing of dialysis.